Health Care & Life Sciences » Pharmaceuticals | Nutex Investments PLC

Nutex Investments PLC | Income Statement

Fiscal year is January-December. All values HUF Millions.
2012
2013
2014
2015
2017
2018
Sales/Revenue
1,225
1,135
1,018
7
9
4
Cost of Goods Sold (COGS) incl. D&A
616
621
506
20
3
2
Gross Income
609
515
512
13
6
2
SG&A Expense
609
525
557
2
10
11
EBIT
-
24
47
15
4
9
Non Operating Income/Expense
8
22
18
153
327
382
Interest Expense
22
65
61
9
20
-
Pretax Income
76
29
83
129
349
389
Income Tax
7
6
12
-
19
14
Consolidated Net Income
83
23
95
129
330
376
Net Income
88
16
97
129
330
376
Net Income After Extraordinaries
88
16
97
129
330
376
Net Income Available to Common
88
16
97
129
330
376
EPS (Basic)
50.00
9.00
37.00
46.05
82.05
28.38
Basic Shares Outstanding
2
2
3
3
4
13
EPS (Diluted)
44.85
9.90
31.91
46.05
82.05
28.38
Diluted Shares Outstanding
2
2
4
3
4
13
EBITDA
74
4
21
4
1
7
Other Operating Expense
-
114
14
2
-
-
Non-Operating Interest Income
-
52
96
174
1
2
Minority Interest Expense
5
7
2
-
-
-

About Nutex Investments

View Profile
Address
Telepes u. 53
Budapest BU 1147
Hungary
Employees -
Website http://www.nutex.hu
Updated 07/08/2019
Nutex Investments Plc engages in the research, development, manufacture, and distribution of pharmaceutical products. Its products include dietary supplements. The company was founded in 1983 and is headquartered in Budapest, Hungary.